Breast Cancer Diagnostics Market Size, Share, Growth, Trends, Production, Consumption, Revenue and Forecast 2020 to 2027

According to Vision Research Reports, the global breast cancer diagnostics market to reach valuaton US$ 9 Bn by 2027 and is projected to expand at a high CAGR during the forecast period.

The report provides the revenue of the global breast cancer diagnostics market for the period 2016–2027, considering 2019 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global breast cancer diagnostics market for the forecast period.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global breast cancer diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global breast cancer diagnostics market. The next section of the global breast cancer diagnostics market report highlights the USPs, which include technological advancements and breast cancer epidemiology.

The report also delves into the competitive landscape of the global breast cancer diagnostics market. Key players operating in the global breast cancer diagnostics treatment market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global breast cancer diagnostics treatment market report.

Major Players

• Companies such as Siemens Healthineers, GE Healthcare, and Hologic, Inc. accounted for major share of the global breast cancer diagnostics market in 2018. Other global players in the market include
  • Abbott Laboratories
  • Koninklijke Philips N.V., C. R. Bard, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holding Corporation
  • Leica Biosystems Nussloch GmbH
  • bioTheranostics, Inc.
  • Myriad Genetics, Inc.
• These players focus on adopting organic and inorganic growth strategies to strengthen product portfolio. These companies have adopted strategies such as collaborations & acquisitions, expansion of geographic footprint, investment in research & development, and manufacture of novel breast cancer diagnostic tools in order to be competitive in the global breast cancer diagnostics market.

Imaging Segment to Lead Global Market

In terms of technique, the global breast cancer diagnostics market has been classified into imaging, tissue biopsy tests, and molecular diagnostics. Imaging is projected to be the leading segment during the forecast period. The imaging segment has been categorized into mammography, breast ultrasound systems, MRI scan, and PET/CT scan. SCS are primarily intended for relieving chronic pain in long-term medical care. Mammography is considered a standard technique and first-line diagnostic test for breast cancer. Significant rise in adoption of digital mammography systems across health care facilities, rise in demand for mammography systems in emerging markets, and increased government funding for breast cancer diagnosis & treatment contributed to the mammography sub-segment’s dominant share of the imaging segment in 2018. The mammography sub-segment has been bifurcated into analog mammography and digital mammography.

Invasive Breast Cancer to Grow at Rapid Pace

Based on cancer type, the global breast cancer diagnostics market has been split into ductal carcinoma in situ and invasive breast cancer. The invasive breast cancer segment dominated the global market in 2018 and the trend is projected to continue during the forecast period. One in every eight women is likely to develop invasive breast cancer during her lifetime. The invasive breast cancer segment has been segregated into invasive ductal carcinoma (IDC), invasive lobular carcinoma, metastatic breast cancer, and others.

Hospitals & Ambulatory Surgery Centers to Lead Global Market

In terms of end user, the global breast cancer diagnostics market has been divided into hospitals & ambulatory surgery centers, diagnostic laboratories, and research & academic institutes. The hospitals & ambulatory surgery centers segment held the largest market share in 2018 and the trend is anticipated to continue during the forecast period. Hospitals and ambulatory surgery centers are the first choice of settings for diagnosis of breast cancer across the globe. Imaging systems such as mammography, CT scan, MRI scan, and ultrasound are costly and are largely purchased by these large institutions. This can be attributed to the hospitals & ambulatory surgery centers segment’s dominant share in 2018.

Research Scope

Breast Cancer Diagnostics Market, by Technique

• Imaging
  • Mammography
    • Analog Mammography
    • Digital Mammography
  • Breast Ultrasound System
  • MRI Scan
  • PET/CT Scan
• Tissue Biopsy Tests
• Molecular Testing

Breast Cancer Diagnostics Market, by Cancer Type

• Ductal Carcinoma In Situ (DCIS)
• Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Metastatic Breast Cancer
  • Others

Breast Cancer Diagnostics Market, by End User

• Hospitals & Ambulatory Surgery Centers
• Diagnostic Laboratories
• Research & Academic Centers

Breast Cancer Diagnostics Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Key Questions Answered in Global Breast Cancer Diagnostics Market Report

• What is the sales/revenue generated by different breast cancer diagnostics across all the regions during the forecast period?
• What are the major drivers, restraints, and opportunities in the global market?
• Which region is set to expand at the fastest CAGR during the forecast period?
• Which segment will have the highest revenue globally in 2027 and which product will expand at the fastest CAGR during the forecast period?

Research Objectives and Approach

The comprehensive report on the global breast cancer diagnostics market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global breast cancer diagnostics market. It is followed by market introduction, market dynamics, and an overview of the global breast cancer diagnostics market, which includes VRR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the breast cancer diagnostics market. The next section of the global breast cancer diagnostics market report highlights the USPs, including technological advancements and breast cancer epidemiology in the global breast cancer diagnostics market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key breast cancer diagnostics manufacturers has been mapped to ascertain the size of the global breast cancer diagnostics market in terms of value. The forecast presented here assesses the total revenue generated by breast cancer diagnostics. In order to provide an accurate forecast, we took into consideration the parent cancer diagnostics market.

The report analyzes the global breast cancer diagnostics market in terms of technique, cancer type, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the breast cancer diagnostics market.